So, it’s been 2 years and 7 months since this company’s IPO. EBR...

So, it’s been 2 years and 7 months since this company’s IPO. EBR still hasn’t made a sale. Yet the SP is about the same as it was when it started!

If I’d waited till now to buy shares, I would have missed the opportunity to accumulate for a much lower dollar cost average than the present price. Why am I so lucky? I began buying slowly while researching the story of wireless endocardial stimulation. As I learnt more my confidence grew and so I continued to buy.

IMO the fact that the SP is the same now as it was in November 2021 - despite no commercialisation- is a massive vote of confidence from the market. And now we are on the cusp of the final PMA module for the FDA. I’m getting excited!

I consider the delay in the final submission as a silver lining, because it means if the premature power depletion issue in some devices hadn’t been identified then the FDA, in my opinion, would have requested EBR’s detailed quality control protocols anyway. Because folks, energy depletion issues are known occurrences for pacemakers and defibrillators.(I trawled the internet and discovered several advisories from Medtronic, for example). That’s why the CEO, I sense, kept stating the revised submission date would allow the company to improve its submission and put the company in a better position to receive FDA approval without further delay.

I’m not surprised EBR haven’t explicitly told the market exactly how it solved its quality control issue. I’m satisfied it’s got to do with certain arrangements with component suppliers. And further testing was required. All good problems to have, and good problems to be challenged by.

Good luck to all holders!